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Smad3 deficiency attenuates renal fibrosis, inflammation, and
apoptosis after unilateral ureteral obstruction.
Background. Transforming growth factor-b (TGF-b) has
been implicated in the development of renal fibrosis induced
by unilateral ureteral obstruction (UUO). However, there is
little information on signaling pathways mediating TGF-b ac-
tivity involved in molecular and cellular events leading to renal
fibrosis induced by UUO. In this study, we sought to determine
whether Smad3, a major signaling component of TGF-b , medi-
ated renal fibrosis induced by UUO.
Methods. Renal fibrosis, inflammation, and apoptosis induced
by UUO were macroscopically and histologically compared be-
tween wild-type mice and Smad3 null mice.
Results. Gross appearance of the kidney after UUO showed
relatively intact kidney in Smad3 null mice [Smad3(−/−) mice]
when compared with that of wild-type mice [Smad3(+/+)
mice]. Renal interstitial fibrosis based on the interstitial area
stained with Aniline-blue or Sirius red solution was signifi-
cantly attenuated in the obstructed kidney of Smad3(−/−) mice
when compared with that of Smad3(+/+) mice. Deposition of
type I and type III collagens were also significantly reduced
in the obstructed kidney of Smad3(−/−) mice. In addition,
the numbers of myofibroblasts, macrophages, and CD4/CD8
T cells infiltrated into the kidney after UUO were signifi-
cantly attenuated in the obstructed kidney of Smad3(−/−) mice
when compared with that of Smad3(+/+) mice. Furthermore,
terminal deoxynucleotidyltransferase-mediated deoxyuridine
triphosphate (dUTP) nick-end labeling (TUNEL) staining af-
ter UUO showed significantly reduced number of tubular apop-
totic cells in the obstructed kidney of Smad3(−/−) mice when
compared with that of Smad3(+/+) mice. Endogenous Smad
pathway was activated in the obstructed kidney after UUO
in wild-type mice as judged by the increase of phosphorylated
Smad2 or phosphorylated Smad2/3-positive cells in renal inter-
stitial area.
Conclusion. Smad3 deficiency attenuated renal fibrosis, in-
flammation, and apoptosis after UUO, suggesting that Smad3
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was a key molecule mediating TGF-b activity leading to real
fibrosis after UUO.
Fibrosis of the tubulointerstitial compartment often
accompanied by inflammation is a major factor in pro-
gressive loss of renal function in patients with a variety
of kidney diseases [1, 2]. Unilateral ureteral obstruction
(UUO) is a representative model of tubulointerstitial re-
nal fibrosis that have many readily quantifiable cellular
and molecular events during the initiation and progres-
sion of renal fibrosis such as inflammation and apoptosis
[3]. Although many factors are involved in the pathophys-
iology of UUO [3], it is well accepted that transforming
growth factor-b (TGF-b) is a key molecule for the devel-
opment of tubulointerstitial fibrosis in UUO [3–10]. It is
generally thought that TGF-b is involved in tissue fibro-
sis including renal fibrosis induced by UUO based on its
capacity to induce extracellular matrix (ECM) produc-
tion, differentiation from fibroblasts into myofibroblasts,
and apoptosis [3, 8, 11–13]. However, there is little infor-
mation on signaling pathways mediating TGF-b activity
that leads to renal fibrosis induced by UUO.
Although TGF-b activates multiple intracellular sig-
naling pathways, recent intense investigations have re-
vealed that Smad proteins constitute the basic compo-
nents of the core intracellular signaling cascade carrying
TGF-b signals from the cell surface directly to the nucleus
[14–16]. The activated TGF-b receptors phosphorylate
Smad2 and Smad3, which form heterotrimeric complex
with Smad4, respectively, and enter the nucleus, bind di-
rectly or indirectly to DNA, and regulate transcription
of many TGF-b target genes in cooperation with vari-
ous transcriptional factors and coactivators/corepressors.
Respective role of Smad2 and Smad3 in TGF-b signal-
ing remains obscure, but reports on Smad2- and Smad3-
deficient mice suggest a distinct role of Smad2 and Smad3
in vivo. Smad3 null mutant mice have been generated in
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different laboratories [17–19], which were viable and fer-
tile, in contrast to Smad2 null mice that show early em-
bryonic lethality [20–22]. So far, the in vivo role of Smads
in renal fibrosis has not been addressed.
In this study, we determined whether Smad3 played
a role in the development of renal fibrosis in UUO by
using Smad3-deficinet mice. We found that Smad3 defi-
ciency attenuated renal fibrosis, inflammation, and apop-
tosis after UUO. Our findings suggest that Smad3 is a
key molecule for cellular and molecular events involved
in UUO and may thus become a novel therapeutic target
for renal fibrosis.
METHODS
Mice
The generation of Smad3delEx8 null mice [Smad3(−/−)
mice] by homologous recombination was described pre-
viously [17] and kindly provided by C. Deng (National
Institutes of Health, Bethesda, MD, USA). In this line
of mice, exon 8 of the Smad3 gene is deleted. The dele-
tion removes the L3 loop, which is necessary for interac-
tion with the TGF-b receptors, and the COOH-terminal
serine-serine-valine-serine (SSVS) consensus phospho-
rylation site. Smad3(−/−) mice were backcrossed for six
generations to C57BL6 mice as previously described [23].
Mice heterozygous for the targeted disruption were inter-
crossed to produce homozygous offspring and kept under
specific pathogen-free conditions in the animal facility of
Juntendo University.
Experimental design
Left kidney UUO was performed in male wild-type
Smad3(+/+) mice and Smad3(−/−) mice, 10 to 12 weeks
of age (N = 6 per group), as previously described
[24]. Briefly, under anesthesia with pentobarbital sodium
(0.3mg/g), UUO was created by complete double ligation
of the left ureter with 2-0 silk suture through an abdom-
inal midline incision. The mice were killed 14 days after
UUO and the obstructed or intact right kidney was im-
mediately weighed, and were fixed in 20% formalin and
embedded in paraffin. Some portions of the kidney were
immediately frozen in Tissue-Tek 22-oxacalcitriol (OCT)
compound for immunohistochemical analysis. All animal
experiments were performed according to the approved
manual of the Institutional Review Board of Juntendo
University. Preliminary studies confirmed that there were
little renal fibrosis, inflammation, and apoptosis in sham-
operated left kidney of Smad3(+/+) and Smad3(−/−)
mice 14 days after the operation.
Histologic examination
The kidney sections (4 lm-thick) were stained with
hematoxylin and eosin, periodic acid-Schiff, Aniline-
blue, or Sirius red solutions. The severity of interstitial
renal fibrosis was evaluated by the calculation of the pos-
itive area of Aniline-blue or Sirius red staining of one
slide section measured with a computerized image ana-
lyzer (KS400) (Carl Zeiss Vision GmbH, Hallbergmoos,
Germany).
Immunohistochemical staining
Interstitial cellularity or collagen deposition was
characterized and quantified after immunoperoxidase
staining for macrophages with F4/80 rat antimouse
macrophage monoclonal antibody (Serotec Ltd., Oxford,
UK), for myofibroblasts with peroxidase-conjugated
murine antihuman a-smooth muscle actin (a-SMA) 1A4
monoclonal antibody (Dako Corp., Carpinteria, CA,
USA), for T cells with rat antimouse CD4 and CD8 anti-
bodies (BD Pharmingen, San Diego, CA, USA), and for
collagens with antibodies against type I or type III colla-
gen (Southern Biotechnology, Birmingham, AL, USA).
Phosphorylated Smad2 or Smad2/3 expression in renal
tissue was immunohistochemically detected by using an-
tibodies against phosphorylated Smad2 (Cell Signaling
Technology Inc., Beverly, MA, USA) or antiphosphory-
lated Smad2/3 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Sections with secondary antibody alone were
negative. Scoring of F4/80-postive cells was determined to
be 0, <5% of positive area in one high power field (×400);
1, 5% to 25% of positive area; 2, 25% to 50% of positive
area; and 3, 50% to 75% of positive area; and 4, >75%
of positive area. Random six high power fields were se-
lected and scored. The number of CD4 or CD8-positive
interstitial cells was counted manually in six random high
power fields. a-SMA–positive area was measured with a
computerized image analyzer (KS400) (Carl Zeiss Vision
GmbH) as described above.
TUNEL assay
In situ detection of DNA fragmentation was per-
formed using terminal deoxynucleotidyltransferase-
mediated deoxyuridine triphosphate (dUTP) nick-end
labeling (TUNEL) staining using in situ tunnel stain-
ing kit (Takara Bio, Inc., Ohtsu, Shiga, Japan) according
to the manufacturer’s recommendation. The number of
TUNEL-positive cells was counted in six random high
power fields.
Data analysis
Statistical analysis was performed using an unpaired
the Student t test. Data were shown as mean±SD and P <
0.05 was considered to be significant.
RESULTS
Phenotype of Smad3 null mice
A significant fraction (∼50%) of Smad3(−/−) mice
kept in our specific pathogen-free facility developed a
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Fig. 1. Gross appearance of the mouse kidney 14 days after unilat-
eral ureteral obstruction (UUO). The left obstructed kidney or right
nonobstructed kidney of Smad3(+/+) and Smad3(−/−) mice were re-
moved 14 days after UUO. Representative pictures of the kidneys from
Smad3(+/+) mice (A and C) and from Smad3(−/−) mice (B and D)
were shown. (C and D) Cross-section of the left and right kidneys. Note
that the obstructed kidney of Smad3(−/−) mice showed relatively in-
tact kidney tissue (much less whitish scar area than that of Smad3(+/+)
mice). Abbreviations are: WT, wild-type; KO, knockout.
wasting syndrome associated with impaired mucosal im-
munity and abscess formation, and died between 1 and
4 months of age as previously described [17]. Yang et al
[17] described that Smad3(−/−) mice exhibited reduced
size compared with their littermate controls and devel-
oped bacterial abscesses near eyes, mandible, salivary
glands, and intestine. This phenotype could be attributed,
at least in part, to impaired chemotactic response
of neutrophils toward TGF-b because the presence of
neutrophils within the abscesses was few [17]. These mice
were not used for the analysis. However, the remain-
ing Smad3(−/−) mice appeared to develop normally, al-
though slightly smaller than their littermates, and lived
for at least 4 to 8 months. The kidneys of these mice
were histologically intact and serum blood urea nitro-
gen (BUN) and creatinine levels were normal at the age
of 10 to 12 weeks (data not shown). Thus, we decided to
use these mice for the following studies and matched the
Smad3(−/−) mice for weight as closely as possible with
their wild-type controls.
Renal fibrosis
To determine whether Smad3 deficiency affected renal
fibrosis in vivo, the severity of renal fibrosis and inflamma-
tion caused by UUO was compared in Smad3 wild-type
(+/+) and Smad3-deficient (−/−) mice. Smad3(+/+) and
Smad3(−/−) mice that underwent UUO were sacrificed
for evaluation of renal lesion 14 days after UUO. As
shown in Figure 1, gross appearance showed remarkable
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Fig. 2. Renal histology of the obstructed kidney after unilateral
ureteral obstruction (UUO). (A) The left obstructed kidney were re-
moved from Smad3(+/+) and Smad3(−/−) mice 14 days after UUO
and the kidney sections were prepared and stained with hematoxylin-
eosin (a and b), periodic acid-Schiff (c and d), Aniline-blue (e and f),
or Sirius red (g and h) solutions. Representative pictures of the kidneys
from Smad3(+/+) mice (a, c, e, and g) and from Smad3(−/−) mice (b,
d, f, and h) are shown. (B) Quantitative analysis of Aniline-blue or Sir-
ius red staining. The Aniline-blue (a) or Sirius-red (b) positive area of
one slide of the left obstructed () or nonobstructed right kidney () of
Smad3(+/+) mice [wild-type (WT)] and Smad3(−/−) mice [knockout
(KO)] 14 days after UUO was measured with a computerized image
analyzer as described in the Methods section. Results were expressed
as percentage of positive area of one slide (N = 6). ∗P < 0.05.
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Fig. 3. Reduced number of a-smooth muscle actin (a-SMA)–positive
cells or deposition of type I and type III collagens in the obstructed kid-
ney of Smad3(−/−) mice after unilateral ureteral obstruction (UUO).
(A) Representative pictures showing immunohistochemical staining
with anti-a−SMA (a and b), anti-type I collagen (c and d), or anti-type
III collagen (e and f) antibody of the kidney sections from Smad3(+/+)
mice [wild-type (WT) left panels] and Smad3(−/−) mice [knockout
reduction of scar formation (whitish area in the kid-
ney) in the obstructed kidney of Smad3(−/−) mice af-
ter UUO when compared with that of Smad3(+/+)
mice. Interestingly, the size of hydronephrosis was big-
ger in Smad3(−/−) mice than that of Smad3(+/+) mice,
suggesting that urine secretion/absorption (or renal func-
tion) was relatively maintained in Smad3(−/−) mice. In-
deed, there was significant difference in the urine volume
deposited in hydronephrosis between Smad3(+/+) mice
and Smad3 (−/−) mice [urine volume Smad3(+/+)
mice 196.7 ± 32.3 lL versus Smad3(−/−) mice 591.7 ±
149.1 lL, P = 0.03, N = 6]. Histologically, quantitative
analysis of Aniline-blue or Sirius red staining after UUO
revealed that the obstructed kidney of Smad3(−/−) mice
had significantly reduced the staining intensity when com-
pared with that of Smad3(+/+) mice (Fig. 2B).
It is now clear that myofibroblasts, a subpopulation of
specialized fibroblasts which express the smooth muscle
isoform of a-actin (a-SMA), play a central role in the
mediation of tissue fibrosis with their augmented abil-
ity to produce ECM and contraction [13]. The number
of interstitial myofibroblasts (a-SMA–positive cells) was
increased in the obstructed kidney of Smad3(+/+) mice
after UUO as previously described [23], but the intensity
of the response was significantly attenuated in the ob-
structed kidney of Smad3(−/−) mice (Fig. 3). In addition,
deposition of type I and type III collagens were signifi-
cantly decreased in the obstructed kidney of Smad3(−/−)
mice (Fig. 3)
Renal inflammation
Hematoxylin-eosin staining of the kidney sections sug-
gested reduced inflammation after UUO in the ob-
structed kidney of Smad3(−/−) mice when compared
with that of Smad3(+/+) mice (Fig. 2). The finding
was supported by quantitative analysis of the number
of F4/80-positive interstitial macrophages, CD4-postive
T cells, and CD8-positive T cells showing reduced num-
ber of these inflammatory cells in the obstructed kid-
ney of Smad3(−/−) mice when compared with that of
Smad3(+/+) mice (Fig. 4).
Renal apoptosis
To determine renal tubular apoptosis after UUO,
the TUNEL assay was performed in paraffin-embedded
(KO) right panels] 14 days after UUO. (B) Quantitative analysis of a-
SMA, type I collagen, or type III collagen positive areas. The a-SMA
(a), type I collagen (b), or type III collagen (c) positive area of one
slide of the left obstructed () or nonobstructed right kidney () of
Smad3(+/+) mice (WT) and Smad3(−/−) mice (KO) 14 days after
UUO was measured with a computerized image analyzer as described
in the Methods section. The results were expressed as percentage of
positive area of one slide (N = 6). ∗P < 0.05.
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Fig. 4. Reduced renal inflammation in the obstructed kidney of
Smad3(−/−) mice after unilateral ureteral obstruction (UUO). (A)
Representative pictures showing immunohistochemical staining with
anti-F4/80 (a and b), CD4 (c and d), and CD8 (e and f) antibodies
of the obstructed kidney sections from Smad3(+/+) (a, b, and c) or
Smad3(−/−) (d, e, and f) mice 14 days after UUO. (B) Quantitative
analysis of immunohistochemical staining with anti-F4/80, CD4, and
CD8 antibodies. (a) Scoring of the F4/80-positive cells of the left ob-
structed () or nonobstructed right kidney () of the mice 14 days after
UUO was determined as described in the Methods section. (b) and (c)
The number of CD4 or CD8-positive interstitial cells of the left ob-
structed () or nonobstructed right kidney () of the mice 14 days after
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Fig. 5. Reduced tubular apoptosis in the obstructed kidney of
Smad3(−/−) mice. (A) Representative pictures showing termi-
nal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate
(dUTP) nick-end labeling (TUNEL) staining of the obstructed kidney
of Smad3(+/+) mice (a) and Smad3(−/−) mice (b) 14 days after uni-
lateral ureteral obstruction (UUO). (B) Quantitative analysis of tubu-
lar apoptotic cells. The number of TUNEL-positive cells was counted
in six random high power fields of the left obstructed () or nonob-
structed right kidney () of Smad3(+/+) mice [wild-type (WT)] and
Smad3(−/−) mice [knockout (KO)] 14 days after UUO (N = 6). ∗P <
0.05.
kidney sections of the mice 14 days after UUO (Fig. 5).
The obstructed kidney of Smad3(+/+) mice showed sig-
nificant higher tubular apoptosis when compared with
nonobstructed kidney of the mice as previously de-
scribed [8]. Similar to the findings in renal fibrosis and in-
flammation, the obstructed kidney of Smad3(−/−) mice
showed significantly lower tubular apoptosis than that of
Smad3(+/+) mice.
Activation of the Smad pathway after UUO
Since the data described above suggested that the
Smad pathway was crucial for the development of UUO,
we asked whether the Smad pathway was indeed acti-
vated in the obstructed kidney after UUO. Because of
limited availability of antibodies against phosphorylated
Smad3 suitable for immunohistochemical staining, we
performed immunohistochemical analysis with antibody
against phosphorylated Smad2, another marker for ac-
tivation of TGF-b signaling. As shown in Figure 6, the
UUO was counted in six random fields under high performance fields.
Wild-type (WT), Smad3(+/+) mice; knockout (KO), Smad3(−/−) mice
(N = 6). ∗P < 0.05.
602 Inazaki et al: Smad3 regulates renal fibrosis
A B
Fig. 6. Increased phosphorylated Smad2-positive cells in renal inter-
stitial tissue after unilateral ureteral obstruction (UUO). Immuno-
histochemical staining with antiphosphorylated Smad2 antibody was
performed in the right nonobstructed kidney (A) and left obstructed
kidney (B) of wild-type mice 14 days after UUO.
immunoreactivity of phosphorylated Smad2 was promi-
nent in the nucleus of cells in the interstitial area of the
kidney after UUO. Morphologic examination suggested
that the positive staining cells observed after UUO in-
duction were mostly infiltrated inflammatory cells and
fibroblast-like cells. Thus, UUO-dependent activation of
Smad2 appeared to occur largely in the cells located or
infiltrated in renal interstitial area. Interestingly, renal
tubular cells appeared to be constitutively positive for
phosphorylated Smad2 staining independent of UUO
induction. To further ascertain these results, we per-
formed immunohistochemical analysis with antibody
against phosphorylated Smad2/3 and had essentially simi-
lar results (Fig. 7). These findings indicated that activation
of the Smad pathway indeed occurred in renal interstitial
cells after UUO.
DISCUSSION
In this study, we demonstrated that Smad3 deficiency
remarkably attenuated renal fibrosis, inflammation, and
apoptosis induced by UUO (Figs. 1 to 5). In addition, we
showed that endogenous Smad2/3 pathway in renal inter-
stitial area was indeed activated after UUO (Figs. 6 and
7). Thus, we concluded that Smad3 was a key mediator
for the development of UUO.
Previous in vitro studies suggested that Smad3 was
critical for important aspects of TGF-b–mediated fi-
brotic, inflammatory, and apoptotic responses, including
ECM production from fibroblasts [25], differentiation
from fibroblasts to myofibroblasts [25], and chemotaxis
of macrophages [27] and induction of cellular apoptosis
[28], all of which were down-regulated in the obstructed
kidney of Smad3(−/−) mice after UUO (Figs. 1 to 5).
Our findings thus suggested that Smad3 mediated these
activities in vivo as well as in vitro. It is most likely that
Smad3 deficiency attenuated pathologic changes in the
kidney after UUO through suppression of these cellular
and molecular events.
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Fig. 7. Increased phosphorylated Smad2/3-positive cells in renal inter-
stitial area after unilateral ureteral obstruction (UUO). Immunohis-
tochemical staining with antibody cross-reacted with phosphorylated
Smad2 and phosphorylated Smad3 was performed in the right non-
obstructed kidney (A and B) and left obstructed kidney (C and D) of
Smad3(+/+) mice [wild-type (WT)] and Smad3(−/−) mice [knockout
(KO)] 14 days after UUO.
The role of Smad3 in the differentiation of myofi-
broblasts (a-SMA–positive cells) is yet controversial;
one paper suggested Smad3 as critical for a-SMA ex-
pression [26], other papers suggested Smad2 [29] or
Smad-independent pathways [13] as important for my-
ofibroblast differentiation. Because we showed that the
number of myofibroblast in the obstructed kidney af-
ter UUO was significantly reduced in Smad3(−/−) mice
(Fig. 3), it should be determined in future study whether
the reduction of myofibroblast number was the direct
or indirect effect of Smad3 deficiency on myofibroblast
differentiation.
Renal interstitial inflammation was remarkably sup-
pressed in the obstructed kidney of Smad3(−/−) mice
as demonstrated by hematoxylin-esoin and periodic
acid-Schiff staining and the number of infiltrating
macrophages and T cells into the kidney (Figs. 2 and 4).
Because Smad3 was critical for macrophage/monocyte
chemotaxis [27, 30], the inhibition of macrophage mi-
gration into the obstructed kidney was most likely due
to reduced macrophage/monocyte chemotaxis in the ab-
sence of Smad3. Although the role of Smad3 in T-cell
chemotaxis remains unclear, it is possible that reduction
of T-cell migration occurred through reduced production
of cytokines/chemokines from macrophages involved in
T-cell chemotaxis.
TUNEL assay showed clear reduction of tubular apop-
tosis in the obstructed kidney of Smad3(−/−) mice
(Fig. 5). Renal tubular apoptosis after UUO was thought
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to contribute to the progressive loss of renal function
and accumulation of ECM surrounding the lost cells [3].
Our findings clearly showed that Smad3 was involved in
renal tubular apoptosis in vivo. However, recently, Dai,
Yang, and Liu [31] reported that TGF-b potentiated re-
nal tubular epithelial cell death by a mechanism indepen-
dent of Smad signaling. It should be therefore determined
whether Smad3 was directly or indirectly involved in in-
duction of renal tubular apoptosis in vivo.
We found that endogenous Smad2 or Smad2/3 was
phosphorylated in cells located or infiltrated in renal in-
terstitial area upon UUO induction in wild-type mice
(Figs. 6 and 7). Thus, UUO-dependent activation of
Smad2 appeared to occur largely in the cells in renal
interstitial area. These results were consistent with up-
regulation of TGF-b in renal interstitial tissue after UUO
as previously described [32]. Mizuno, Matsumoto, and
Nakamura [32] reported that interstitial cells positive for
TGF-b (e.g., macrophages, spindle-shaped fibroblast-like
cells) were noted in the interstitial area of the mouse kid-
ney after UUO. In addition, we noted that renal tubular
cells appeared to be constitutively positive for phos-
phorylated Smad2 staining regardless of UUO induction
(Fig. 6). Future studies should thus determine the biologic
significance of constitutive endogenous Smad2 activation
in renal epithelial cells as well as that of activation of en-
dogenous Smad2 in renal interstitial area after UUO.
Lan et al [33] recently showed that gene transfer of
Smad7, an inhibitor of TGF-b/Smad signaling, into the
kidney inhibited renal fibrosis induced by UUO in rats.
Most recently, Sato et al [34] reported that Smad3 de-
ficiency protected against renal tubulointerstitial fibrosis
induced by unilateral ureteral obstruction associated with
blockade of epithelial-mesenchymal transition (EMT) as
judged by a-SMA staining, abrogation of monocyte influx
and collagen accumulation, which was essentially same
findings as ours. Taken together with our findings, Smad3
is most likely to be a key mediator for renal fibrosis in-
duced by UUO.
CONCLUSION
We clearly showed that Smad3 deficiency remarkably
attenuated renal fibrosis, inflammation, and apoptosis in-
duced by UUO. Modulation of Smad3 expression/or ac-
tivity may therefore become potential therapeutic target
for efficient therapy for obstructed kidney diseases or re-
nal fibrosis.
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